Norepinephrine biosynthesis

Norepinephrine biosynthesis is the multi-step enzymatic pathway responsible for the production of the catecholamine neurotransmitter and hormone norepinephrine, also known as noradrenaline. The process begins with the amino acid tyrosine, which is converted to L-DOPA by the rate-limiting enzyme tyrosine hydroxylase, followed by decarboxylation to dopamine by aromatic L-amino acid decarboxylase, and finally hydroxylation to norepinephrine by dopamine beta-hydroxylase [1, 4]. This synthesis occurs primarily in the locus coeruleus of the brainstem, postganglionic sympathetic neurons, and the adrenal medulla [2, 10]. Norepinephrine plays a critical role in the "fight-or-flight" response, regulating arousal, cardiovascular stability, and attention [1, 10]. Dysregulation of this pathway is linked to conditions such as attention-deficit hyperactivity disorder (ADHD), depression, hypertension, and pheochromocytoma [3, 11]. Pharmacological modulation involves inhibiting specific enzymes, such as using metyrosine to block tyrosine hydroxylase in pheochromocytoma management, or providing synthetic precursors like droxidopa to treat neurogenic orthostatic hypotension [6, 12].

Other names

Norepinephrine synthesisNoradrenaline biosynthesisCatecholamine biosynthesisAdrenergic synthesis pathway

Inhibition of rate-limiting enzymes (e.g., tyrosine hydroxylase or dopamine beta-hydroxylase); inhibition of aromatic L-amino acid decarboxylase; supplementation of metabolic precursors (e.g., L-DOPA or droxidopa) to bypass enzymatic blocks or deficiencies.